/PRNewswire/ Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from.
Sweden’s probiotics firm Probi have revealed details of a new collaboration with Perrigo in a pact looking to launch a series of probiotic concepts for digestive and immune health within the European region.
While financial terms agreed with the American Irish–pharmaceuticals firm were not disclosed, the go-to-market plan will cover 14 European countries with the first product launch expected later this year.
“We see the collaboration between Probi and Perrigo as an important step in our commercial efforts in offering clinically documented probiotic products to European consumers in partnership with successful consumer healthcare companies,” says Tom Rönnlund, CEO at Probi.
Share this article
Share this article
DUBLIN and GRAND RAPIDS, Mich., Jan. 11, 2021 /PRNewswire/ Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of
Quality, Affordable Self-Care Products, announced today a formal partnership with Michigan State University (MSU), connecting the university s clinical and research expertise with Perrigo s product innovation, manufacturing scale and retail partnerships to empower consumers to take control of their self-care needs.
This collaboration brings together premier industry and academic thought leaders that share a passion for enhancing the health and well-being of society, with a focus on research and clinical outcomes, retail and pharmacy experiences and technology and product innovations.